Sign inJoin waitlistJoin the waitlist

Heather McArthur

Clinical Director, Breast Cancer Program, Simmons Comprehensive Cancer Center · University of Texas Southwestern Medical Center

Credentials: · · · · ·

History

Breast Cancer Program · University of Texas Southwestern Medical Center
Present
University of Texas Southwestern Medical Center
Present

British Columbia Cancer Vancouver Centre (2004-
2004–2006
University of Calgary (2001-
2001–2004
University of Toronto
UNIV OF TORONTO, TORONTO
1997–2001

Research

Pembrolizumab for Early Triple-Negative Breast Cancer
New England Journal of Medicine · 2020 · 2,567 citations
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
New England Journal of Medicine · 2022 · 1,014 citations
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
New England Journal of Medicine · 2024 · 441 citations

CH
Clifford Hudis
25 papers
David Page
15 papers · 1 as a fellow
PM
Patrick Morris
12 papers
Lajos Pusztai
11 papers
AH
Alice Ho
10 papers
LN
Larry Norton
10 papers
Alexis LeVee
9 papers · 9 as a fellow
JO
Joyce O'Shaughnessy
9 papers
MD
Maura Dickler
7 papers
RB
Reva Basho
7 papers · 1 as a fellow
Rita Nanda
7 papers
Elizabeth Mittendorf
6 papers

Clinical trials

Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer
Principal investigator · Active not recruiting · Phase 2
University of Texas Southwestern Medical Center
2019–2029
Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]
Principal investigator · Active not recruiting · Phase 2
University of Texas Southwestern Medical Center
2019–2029
Pre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast Cancer
Principal investigator · Completed · Phase 1
Memorial Sloan Kettering Cancer Center
2011–2014